Business Context and Reporting Period
This Form 6-K filing by Brainsway Ltd., a foreign private issuer, covers the month of November 2023. The report was filed on November 20, 2023, and is incorporated by reference into the Company's Registration Statements on Form S-8 and Form F-3.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a specific corporate event rather than a financial results announcement.
Material Changes and Corporate Developments
- Market Expansion: A Louisiana insurer has expanded access to Brainsway's Deep TMSTM technology.
- Impact: This expansion covers approximately 1.9 million lives, potentially increasing the addressable market for the company's depression treatment solutions in that region.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management commentary on future outlook, specific risks, contingencies, or unusual items beyond the disclosed market expansion.
Investor Verification Checklist
- Verify the specific terms of the agreement with the Louisiana insurer regarding reimbursement rates and coverage criteria.
- Assess the potential revenue impact of adding 1.9 million covered lives to the Deep TMSTM addressable market.
- Review subsequent filings for any updates on the commercialization progress resulting from this expansion.